The study found that epilepsy-associated disability-adjusted life years were concentrated in low- and lower-middle-income countries, with significant regional inequality. Progress has been made in China, including declining mortality rates, but challenges persist, particularly in rural areas where treatment gaps reach 60%–90%.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateAug 14, 2026
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
Researchers analyzed EBRAINS-hosted brain data to determine that whole-brain activity patterns predict stimulation outcomes better than local recordings. Targeting specific sensorimotor and visual networks reduces response variability by up to 24%. This study highlights the value of open datasets for enabling large-scale analyses.
Researchers at Kennedy Krieger Institute discovered that memory consolidation during sleep depends on coordinated activity among three brain regions, disrupting this activity impairs memory performance. Epileptic spikes can also interfere with brain activity, leading to cognitive effects in patients with epilepsy.
SourceKennedy Krieger Institute·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateJul 27, 2026
Researchers developed a personalized gene therapy that dramatically reduced seizures and sparked developmental gains in two children with SCN2A-related DEE, allowing one to walk independently. The therapy targets the root genetic cause of the condition, producing measurable improvement.
SourceUniversity of California - San Diego·JournalNature Medicine·DateJul 21, 2026
Researchers at Texas Children's Hospital have uncovered a novel biological pathway that can lead to seizures when disrupted. This finding provides a new approach for improving genetic diagnosis and treatment for epilepsy cases with unknown origins. The study also reveals that specific combinations of defective genes can cause seizures,...
SourceTexas Children's Hospital·JournalJournal of Clinical Investigation·DateJul 16, 2026
Researchers at Gunma University have identified a compact genetic switch that could revolutionize the treatment of drug-resistant epilepsy. The discovery, published in Molecular Therapy, offers new avenues for addressing this debilitating condition.
SourceGunma University·JournalMolecular Therapy·DateJul 16, 2026
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers discovered that reducing microglial activity worsened abnormal electrical activity and increased seizure-like events in a mouse model of Alzheimer's disease. Microglia are not just drivers of inflammation but also perform important housekeeping functions to maintain healthy brain activity.
SourceTrinity College Dublin·JournalBrain·TypeExperimental study·DateJul 15, 2026
Researchers at Texas A&M University have found a way to intervene early in traumatic brain injuries using a natural, gut-derived chemical that prevents post-traumatic epilepsy from taking root. The treatment reduced brain inflammation, improved memory and mood, protected brain cells, made seizures both rarer and harder to trigger.
SourceTexas A&M University·JournalExperimental Neurology·DateJul 15, 2026
A novel gene promoter called cmGAD67 shows promise for treating drug-resistant epilepsy by selectively stimulating inhibitory neurons. The study found that the promoter drove strong and highly selective gene expression in specific brain regions, reducing abnormal electrical activity and seizures.
SourceGunma University·JournalMolecular Therapy·TypeExperimental study·DateJul 9, 2026
Researchers have discovered a biomarker that can predict and prevent epileptic seizures by detecting a period of neuronal silence before the seizure occurs. The use of this biomarker in neuromodulation therapy has shown promise in reducing seizure duration by up to 93%.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalScientific Reports·DateJul 8, 2026
Researchers created a detailed map of the pulvinar, a deep brain region that could help doctors precisely target brain stimulation therapies for people with drug-resistant epilepsy. The study reveals that brain regions separated by only a few millimeters connect to entirely different brain networks.
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Adults with both epilepsy and hearing loss who use hearing aids have a 23% lower risk of developing dementia. The association was observed consistently across all analyses, suggesting that correcting hearing impairment may have a greater impact on dementia risk in people with reduced cognitive reserve.
A new EPI-SLEEP study will investigate the impact of personalized in-ear sleep technology on sleep disturbances and circadian health in adults with epilepsy. The study aims to generate robust evidence for a low-risk approach to improving sleep without adding medication burden.
Researchers will investigate the link between SYNGAP1 protein deficiency, cilia dysfunction, and clinical symptoms of SYNGAP1-Related Disorders. The study aims to inform rational drug design and provide new insights for targeted therapies.
A study by the American Academy of Neurology found that people with epilepsy living in rural areas had poorer health outcomes, including higher mortality rates, longer hospital stays, and reduced access to specialized care. The study highlights the need for improved access to epilepsy care in rural areas.
SourceAmerican Academy of Neurology·JournalNeurology·DateJun 3, 2026
The CURE SYNGAP1 COLLECTIVE is a collaborative framework uniting independent SYNGAP1 charities worldwide to accelerate treatments for individuals with SYNGAP1-Related Disorders. The Collective focuses on three primary pillars: research, industry engagement, and patient advocacy.
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
CURE SYNGAP1 invests in remote assessment tools to broaden access to clinical care and trials for patients with SYNGAP1-Related Disorders. The study aims to evaluate the validity of a standardized remote developmental assessment to reduce travel burden.
A new study found that a smartwatch application accurately detected tonic-clonic seizures in people with epilepsy, with a low rate of false alarms. The app had an overall sensitivity of 98% and was associated with fewer false alarms compared to other devices.
SourceAmerican Academy of Neurology·JournalNeurology Open Access·DateMay 27, 2026
The 2025 Impact Report showcases tangible progress made by CURE SYNGAP1, including almost $1.8M in grants and the most successful SYNGAP1 Science Conference ever. The report highlights the organization's focus on Collaboration, Transparency, and Urgency, driving momentum for clinical trials and treatments.
CURE SYNGAP1 partners with RARE-X to accelerate ProMMiS study's Patient-Reported Outcome measure data collection. This investment enables the centralized collection of high-quality PROs, essential for regulatory approval and therapy development.
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
A study published in Chinese Neurosurgical Journal shows that heat-based therapy, such as RF-TC, alters brain network connectivity in patients with medically refractory epilepsy. This may help predict treatment response and guide personalized interventions.
SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeObservational study·DateMay 15, 2026
A research team at the University of Zurich has developed a new gene editing approach that correctly treats the genetic mutation causing hereditary epilepsy in mice. The therapy improves communication between nerve cells, reduces febrile seizures, and increases survival rates.
SourceUniversity of Zurich·JournalScience Translational Medicine·TypeExperimental study·DateMay 13, 2026
Researchers at The Hospital for Sick Children have developed a method to predict attention lapses in children using real-time brain signals. A brief targeted intervention can restore focus when delivered exactly at the moment of predicted lapse.
SourceThe Hospital for Sick Children·JournalNature Neuroscience·DateMay 13, 2026
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
A preclinical study using precision gene editing targets and corrects the root cause of Dravet syndrome, a rare form of childhood epilepsy. The approach demonstrates significant success in treating the disease, including improved survival rates and reduced seizures.
SourceJackson Laboratory·JournalScience Translational Medicine·TypeExperimental study·DateMay 13, 2026
A large population-based study found that children with epilepsy have a significantly higher risk of also having autism spectrum disorder. The study highlighted key differences between children with co-occurring conditions, including intellectual disability and age of diagnosis.
SourceWiley·JournalDevelopmental Medicine & Child Neurology·DateMay 6, 2026
Researchers suggest treatment could start during pregnancy to prevent brain damage and reduce neurological harm. A new RNA-based therapy reduces abnormal electrical currents in patient-derived excitatory neurons.
SourceNorthwestern University·JournalNature Communications·DateApr 30, 2026
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
Researchers discovered that interictal epileptiform discharges (IEDs) occur in a predictable pattern, unfolding sequentially in individual neurons. Nearly 80% of IED-involving neurons are also involved in language and perception, suggesting the brain blips can derail cognition.
SourceUniversity of California - San Francisco·JournalNature Neuroscience·DateApr 30, 2026
Researchers at UCLA mapped how Down syndrome disrupts prenatal neuron development, leading to cognitive and sensory processing differences. The study found altered developmental sequences and cell populations that may contribute to the condition's effects.
SourceUniversity of California - Los Angeles Health Sciences·JournalScience·DateApr 23, 2026
A recent study published in Neurology found that people with epilepsy who experience poor sleep are at a higher risk of developing dementia compared to those without epilepsy. Optimal sleep, defined as six to eight hours per day, is associated with better cognitive function and lower dementia risk.
NYU Langone Health experts present platform talks on practical strategies to counter medical misinformation, phase 3 X-TOLE2 trial results for novel epilepsy treatment, and exploring healthcare accessibility for patients with disabilities. The Department of Neurology features over 80 presentations from faculty members.
SourceNYU Langone Health / NYU Grossman School of Medicine·DateApr 19, 2026
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
A large Nordic register-based study finds that high-dose folic acid supplementation before pregnancy reduces the risk of major congenital anomalies by 45% in women taking antiseizure medication. Starting folic acid after pregnancy onset has no protective effect.
SourceAarhus University·JournalJournal of Neurology Neurosurgery & Psychiatry·TypeObservational study·DateApr 16, 2026
A new study by University College London found that gabapentinoids, prescribed for chronic pain, double the risk of hospitalization for drug poisoning when combined with benzodiazepines or opioids. The risk persists even after starting gabapentinoid treatment, suggesting they may not be an effective solution to reduce poisoning risks.
SourceUniversity College London·JournalPLOS Medicine·TypeObservational study·DateApr 16, 2026
The organization welcomes Craig Bower, Allison Hirsch Hadar, Susan Johnson, Andrew Schillaci, and Ed Warshauer to its Board of Trustees, succeeding outgoing members. These new leaders join a mission primed for global impact, signaling a reinforced commitment to accelerating safe, effective, and targeted therapies.
Researchers used base editing to correct the SCN8A gene mutation responsible for severe inherited epilepsy. The approach successfully eliminated or reduced seizures and improved brain function in lab mice, offering new hope for treating genetic epilepsies.
SourceUniversity of Virginia Health System·JournalJournal of Clinical Investigation·DateApr 7, 2026
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
CURE SYNGAP1 accelerates treatment development for SYNGAP1-Related Disorders through rigorous research and family-led leadership. The organization has funded over $8 million in grants and identified over 1,707 patients to date.
Research reveals associations between antiseizure drugs and neurodevelopmental disorders in children, with valproate and zonisamide linked to increased risks. The study highlights the need for continued monitoring of new antiseizure drugs and further evaluation of their safety during pregnancy.
SourceBMJ Group·JournalThe BMJ·TypeObservational study·DateMar 11, 2026
A new review outlines the scientific explanations behind ketogenic diets' therapeutic benefits for epilepsy, including their ability to strengthen brain energy systems, reduce inflammation, and protect neurons. The review highlights the need for further research, particularly in adults, to develop new therapies that mirror the diet's e...
SourceUniversity of Colorado Anschutz·JournalThe Lancet Neurology·DateMar 11, 2026
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers developed a new noninvasive brain stimulation technique by combining focused ultrasound with electrical stimulation, producing stronger, targeted brain responses. This approach, called transcranial electro-acoustic stimulation, clarifies conflicting results in the field and introduces a new approach to noninvasive brain sti...
SourceCollege of Engineering, Carnegie Mellon University·JournalNature Communications·DateMar 10, 2026
A mini-review synthesizes large-scale genomic findings to illuminate the polygenic architecture underlying common epilepsies. Rare genetic variants contribute to epilepsy risk, with shared biological pathways involving ion channel function and synaptic excitability
SourceGenomic Press·JournalGenomic Psychiatry·TypeLiterature review·DateMar 10, 2026
Researchers discovered that FOXJ3 gene mutations disrupt brain layer formation, leading to drug-resistant epilepsy. The study reveals a critical link between abnormal brain development and epilepsy, identifying FOXJ3 as a key genetic and molecular cause.
SourceNational Yang Ming Chiao Tung University·JournalNature Communications·DateMar 9, 2026
Mayo Clinic researchers have identified a hidden 'movement map' deep within the brain, which could help surgeons reduce side effects from epilepsy procedures and guide future treatments for speech and movement disorders. The discovery was made using advanced brain-recording technology to create individualized maps of patients' brains.
SourceMayo Clinic·JournalProceedings of the National Academy of Sciences·DateMar 4, 2026
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
A new medication called zorevunersen has been found to reduce seizures in children with Dravet syndrome by up to 91%, improving their quality of life and behavior. The study, led by University College London and Great Ormond Street Hospital, also showed the potential to reduce the impact of the condition on mental processes.
SourceUniversity College London·JournalNew England Journal of Medicine·DateMar 4, 2026
Phase 1/2a clinical trials demonstrate significant seizure reduction and improvement in symptoms of Dravet syndrome, a genetic disorder affecting cognitive function, motor skills, and behavior. The treatment, zorevunersen, targets the underlying cause of the disease by enhancing the normal SCN1A gene.
SourceAnn & Robert H. Lurie Children's Hospital of Chicago·JournalNew England Journal of Medicine·DateMar 4, 2026
Potassium KCNQ2/3 channels need full functionality to work properly in the brain and reach their correct location. This is linked to their regulation by protein ankG. Altering channel functionality affects neuronal excitability and may contribute to developing new therapeutic strategies for epilepsy.
SourceThe University of Osaka·JournalProceedings of the National Academy of Sciences·TypeImaging analysis·DateMar 3, 2026
Dr. Dennis Lal has been appointed as the new executive director of the Center for Innovation in Health Informatics at UT Arlington, succeeding Marion Ball. He will lead initiatives on precision health, clinical AI, and health care-scale informatics.
A ketogenic diet causes physical changes in brain cells that affect how they send information to one another, dampening the strength of signals between them. This quieter neural landscape might explain how the diet calms overactive electrical signaling characteristic of epileptic seizures.
SourceWashU Medicine·JournalCell Reports·TypeExperimental study·DateFeb 25, 2026
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
A Mayo Clinic study found that the brain enters a deep sleep state after a seizure, mimicking memory storage and strengthening disease. This phenomenon, called seizure-related consolidation, could help explain why epilepsy worsens over time and why memory and mood problems are common in people with the condition.
Researchers created a simplified, scalable human cell model to study coordinated brain rhythms. They found that inhibitory signaling mediated by GABA helped promote sleep and prevent seizures, while potassium channel perturbations influenced rhythmic organization in distinct ways.
SourceSanford Burnham Prebys·JournalNeurobiology of Disease·TypeExperimental study·DateFeb 18, 2026
Rice bioengineer Jerzy Szablowski has been awarded a Sloan Research Fellowship for his innovative work on noninvasive methods to communicate with the brain. He aims to develop versatile platform technologies to obtain new types of research data and treat multiple diseases.
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
This systematic review compares the efficacy, safety, and quality of life outcomes associated with stereoelectroencephalography-guided temporal lobe resection (TLR) and responsive neurostimulation (RNS) in adults with drug-resistant TLE. Key findings include higher seizure freedom rates for TLR and better cognitive preservation with RNS.
SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateFeb 13, 2026
Dr. Paul Donlin-Asp will investigate the molecular functions and regulation of local SYNGAP1 protein synthesis, aiming to advance therapies for SYNGAP1-related Disorders. The project seeks to map mechanisms controlling SYNGAP1 protein production in neurons.
The UTA Pediatric Brain Health and Neurosciences Center will focus on developing novel treatments for drug-resistant epilepsy in children. Dr. Papadelis' team has already made significant discoveries in identifying the epileptogenic zone and predicting surgical outcomes.
Researchers have developed a long, needle-thin brain electrode with channels that enables neural signal recording and precisely targeted medication delivery across different brain regions. The technology has primarily been developed for basic research but may be important for future treatments in epilepsy and other neurological diseases.
SourceTechnical University of Denmark·JournalAdvanced Science·DateFeb 5, 2026
Dr. Àlex Bayés Puig advances SYNGAP1 research with a new SynGAP biomarker study funded by CURE SYNGAP1, enabling the detection of SYNGAP1 protein levels in blood cells. This breakthrough approach has the potential to transform diagnostics and clinical research for SYNGAP1 patients.
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
A new study suggests an experimental peptide, TXM-CB3, reduces recurring seizures and protects brain function in preclinical studies. Early treatment with the peptide shows significant benefits in reducing seizure activity and improving cognitive function.
SourceThe Hebrew University of Jerusalem·JournalRedox Biology·TypeExperimental study·DateJan 28, 2026
A Swedish study of prematurely born adults found increased morbidity in physical and mental health, yet they reported a high quality of life. The study, which followed participants from birth to age 26-29, suggests that premature birth does not necessarily limit daily life.
SourceUppsala University·JournalThe Journal of Pediatrics·TypeMeta-analysis·DateJan 27, 2026
Researchers at the University of Virginia Health System have discovered how the keto diet protects against epilepsy seizures by regulating brain cell activity. The team found that a specific cellular receptor, HCAR2, plays a crucial role in reducing seizures, and may be targeted for new treatments.
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
A new UK-wide clinical trial evaluated a self-guided behavioural sleep programme for children with epilepsy, resulting in improved sleep duration of 16.5 minutes. However, the main issue was engagement, as only half of those given access to the resources used them.
SourceKing's College London·JournalScientific Reports·TypeExperimental study·DateJan 7, 2026
Scientists at Lund University have created a new method to directly reprogram glial cells into parvalbumin neurons, which can help regulate brain activity and potentially treat disorders such as schizophrenia and epilepsy. The breakthrough could lead to therapies that replace lost or damaged brain cells in the future.
SourceLund University·JournalScience Advances·TypeExperimental study·DateJan 1, 2026
Researchers found that eradicating aging cells in mice with a combination of dasatinib and quercetin reduced senescent cells, improved memory, and decreased seizures. The study's results suggest a potential new approach to treating temporal lobe epilepsy.
SourceGeorgetown University Medical Center·JournalAnnals of Neurology·DateDec 22, 2025